Predicting stomach pain in children with IgA vasculitis
Part of Blood & lymphatic, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study looks at a blood test done when a child is first diagnosed with IgA vasculitis (also called Henoch-Schönlein purpura) to see if it can predict stomach or intestine problems. It involves one extra blood draw at diagnosis and a follow-up visit a few weeks later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with IgA vasculitis by a doctor.
- Your child is between 2 and 18 years old.
- A blood sample can be taken at the time of diagnosis.
- You can bring your child back for a check-up 2–4 weeks after diagnosis.
- A parent or guardian must agree to the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a skin biopsy to look at “gene signals” (transcriptomics) in patients with active vasculitis that shows up on the skin. It may help researchers understand what is happening in your disease and how different types of vasculitis differ.
This trial tests a targeted medication called Telitacicept for children and teens with kidney inflammation caused by IgA vasculitis. It aims to reduce protein in the urine and protect kidney function.
This study looks at treatment strategies for children with IgA vasculitis (also called Henoch-Schönlein purpura) when it mainly affects the stomach and intestines and symptoms do not improve with standard steroid dosing. It may help find better ways to control the illness early and prevent serious complications.
This study looks for blood test markers that may help diagnose vasculitis and predict how it may go. You may be offered additional blood sampling if you have certain active vasculitis conditions.
This trial is looking at how severe illness affects the gut. It tests if measuring certain markers in blood and urine can help doctors understand and treat gut problems in ICU patients.
This trial looks at how bacteria in the gut (microbiome) and substances in the body (metabonomics) relate to IgA nephropathy, a kidney condition. The goal is to understand patterns that may help explain the disease and improve future care.
Hear when a new IgA Vasculitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.